EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first.
Back in January, the European Commission...
Longevity biotech exclusive Q&A with Cambrian Biopharma's Chief Operating Officer.
Recently we reported on Cambrian Biopharma, a New York-based biotech which raised $60 million to...
Longevity biotech exclusive Q&A with Cambrian Biopharma's Chief Operating Officer.
Recently we reported on Cambrian Biopharma, a New York-based biotech which raised $60 million to...
Introducing Eleanor Sheekey and The Sheekey Science Show – taking science communication to a whole new level.
The Sheekey Science Show looks at all sorts of science...
Longevity, biotech, investment, sustainability and ethics: Jim Mellon's new book, MOO'S LAW, addresses the opportunities and challenges of our need for protein.
Getting time with...
Highlights from longevity research, trials and funding in January 2021
Hundreds of companies are working to develop treatments to slow down aging and increase healthy...
Compound that extends lifespan in worms also slows bone loss in mice.
Scientists at the Buck Institute for Research on Aging conducted a longitudinal and functional study...
Juvenescence's Greg Bailey on transformative scientific opportunities, immuno-resilience, modifying aging and funding.
Continuing our series of interviews with our Advisory Panel members, we spoke to Greg...
Dr Lynne Cox explains the importance of geroprotectors – especially during COVID-19.
This month The Lancet launches its own journal on Longevity, publishing clinically-focused Longevity and...
Dr Nir Barzilai predicts that rapamycin could decrease severity of coronavirus in the elderly by 50%.
Longevity.Technology: When it comes to the world of Longevity...
EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first.
Back in January, the European Commission...
Leading biogerontologist João Pedro de Magalhães says that longevity pharmacology has come of age, and discusses rapamycin, Calico and human trials.
The longevity space is...
Longevity biotech exclusive Q&A with Cambrian Biopharma's CEO – hallmarks of aging and classifying aging as a disease.
Dr James Peyer is Cambrian's CEO and...
Part 2 of our interview with NuSirt's founder explores clinical trials and commercialisation of nutraceutical and pharmaceutical combinations with leucine.
In the first part of...
Sci-fi or reality? Artificial organs may soon be the solution for those suffering from all forms of hypothyroidism.
The role of the thyroid gland is...
EU Green Paper on Ageing is a wish list, but the European Longevity Initiative is proposing a foundation first.
Back in January, the European Commission...
Determined to bring longevity opportunities to a wider market, JUVICELL packs ten ingredients into its longevity supplement.
Over the coming weeks, we will be bringing...
Can biological age be set back by "making the clock tick backwards"? Scientists suggest that a partial phenotypic rejuvenation can be gained.
Since the discovery...
